UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
Related Articles

News
Protein Clumps in ALS Neurons Provide Potential Target for New Therapies
July 1, 2019
sandiegobiotech
News
Comments Off on Protein Clumps in ALS Neurons Provide Potential Target for New Therapies

News
Major Gift Focuses Efforts on a Rare, but Devastating, Genetic Eye Disease
December 15, 2021
sandiegobiotech
News
Comments Off on Major Gift Focuses Efforts on a Rare, but Devastating, Genetic Eye Disease
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition. Click here to view original post… […]

News
Home-Based Tools Can Help Assess Dementia Risk and Progression
March 28, 2019
sandiegobiotech
News
Comments Off on Home-Based Tools Can Help Assess Dementia Risk and Progression